Cervical cancer remains one of the most preventable cancers, yet barriers to traditional screening continue to leave many women underprotected. Australia’s recent expansion of self-collection options represents a significant step toward more equitable cervical cancer prevention—but new research reveals that the success of this innovation depends heavily on healthcare practitioners embracing the change.
At June Health, we’re committed to making healthcare more accessible and personalised for everyone. The evolution of cervical screening in Australia offers valuable insights into how innovative approaches can break down traditional barriers to preventive care—something that aligns perfectly with our mission to put individuals at the centre of their health journey.
The Promise of Self-Collection
Self-collection for HPV testing allows individuals to collect their own vaginal sample using a simple swab, which is then tested for human papillomavirus—the virus responsible for nearly all cervical cancers. This approach offers numerous advantages over traditional Pap smears, including increased privacy, reduced embarrassment, and elimination of the discomfort associated with speculum examinations (Camara et al., 2021).
The evidence supporting self-collection is compelling. Research consistently shows that self-collected samples are just as accurate as clinician-collected samples for detecting HPV and precancerous changes (Arbyn et al., 2018). More importantly, self-collection has been shown to significantly increase screening participation, particularly among women who face barriers to traditional screening methods—exactly the kind of patient-centred innovation that June Health champions.
Australia’s Journey from Restriction to Universal Access
Australia’s path to implementing self-collection highlights both the potential and the challenges of healthcare innovation. When self-collection was first introduced in December 2017, access was heavily restricted—available only to women aged 30 and older who were under- or never-screened and who declined clinician-collected samples (Creagh et al., 2024).
The results were disappointing. Despite the known benefits of self-collection, uptake remained extremely low, with only 0.1% of all screening tests being self-collected in the first two years—representing less than 1% of eligible women (Smith et al., 2022). This poor uptake prompted a policy review, leading to the introduction of universal access in July 2022, allowing all screen-eligible individuals to choose between self-collection and clinician collection.
This shift from a one-size-fits-all approach to offering genuine choice reflects the same philosophy that drives June Health’s approach to personalised healthcare—recognising that different people have different needs, preferences, and circumstances.
The Critical Role of Healthcare Practitioners
A groundbreaking study by Creagh et al. (2024) provides the first real-world examination of how healthcare practitioners responded to this policy change. The research, conducted with 27 practitioners from 10 primary care sites in Victoria, reveals crucial insights about the implementation of universal self-collection access.
The findings are both encouraging and concerning. While practitioners were generally supportive of expanding access to self-collection, only 70% of practices had adopted or planned to adopt universal access into routine care. This gap between policy and practice has significant implications for the equity goals that self-collection is meant to achieve—and mirrors challenges we see across healthcare when innovations struggle to translate from evidence to everyday practice.
Understanding Practitioner Concerns
The research identified several key concerns that influence practitioners’ willingness to offer self-collection:
Accuracy and Sample Quality
Many practitioners worried about patients’ ability to collect adequate samples correctly. However, real-world data from Australia shows that only 2% of self-collection tests yield unsatisfactory results—similar to rates for traditional cervical cytology (Creagh et al., 2024). This suggests that practitioner concerns about sample quality may be overstated and highlights the importance of evidence-based decision-making in healthcare.
Loss of Examination Opportunities
Some practitioners expressed concern about missing opportunities to perform pelvic examinations that might detect other health issues. However, current clinical guidelines clearly state that routine pelvic examinations are not necessary for asymptomatic individuals, with major medical organisations recommending against routine pelvic exams in the absence of symptoms (Qaseem et al., 2014).
Time and Resource Constraints
Practitioners reported challenges in finding time to explain options, train staff, and implement new processes. The competing demands of acute care often relegated preventive services like cervical screening to lower priority within consultations. This reflects a broader challenge in healthcare delivery that June Health addresses through our focus on streamlined, accessible care pathways.
Bridging the Implementation Gap
The study’s findings highlight a critical challenge in healthcare innovation: the gap between evidence-based policy and real-world implementation. For self-collection to achieve its potential in improving screening equity, several strategies are essential:
Education and Communication
Ongoing education for healthcare providers should address specific concerns about sample adequacy and accuracy. Clear communication about the evidence supporting self-collection, including real-world performance data, can help dispel misconceptions. At June Health, we understand that informed healthcare providers are essential partners in delivering patient-centred care.
Implementation Support
Practices need targeted support to integrate self-collection into their workflows. This includes training materials, workflow optimisation guidance, and potentially financial incentives to offset implementation costs. This kind of systematic support for healthcare innovation is something June Health actively promotes through our partnerships with healthcare providers.
Patient Education
Comprehensive patient education materials, available in multiple languages and culturally appropriate formats, are crucial for ensuring that individuals can make informed choices about their screening options. This aligns with June Health’s commitment to empowering individuals with the information they need to make decisions about their health.
Global Implications
Australia’s experience with self-collection implementation offers valuable lessons for other countries considering similar programs. As of 2021, 17 countries had implemented self-collection as a primary or alternative screening modality, with many more planning transitions to HPV-based testing that includes self-collection options (Serrano et al., 2022).
The practitioner-supported delivery model used in Australia—where self-collection is offered through primary care consultations rather than direct mail-out programs—maintains the important role of healthcare providers in screening and follow-up care. However, it also means that the availability of self-collection depends entirely on practitioner adoption.
Looking Forward: The June Health Perspective
The introduction of universal access to self-collection represents a significant advancement in cervical cancer prevention. However, realising its full potential requires addressing the implementation challenges identified in recent research. Success depends not only on having evidence-based policies but also on ensuring that healthcare practitioners have the support, education, and resources needed to implement these innovations effectively.
At June Health, we see this as an opportunity to demonstrate how technology and patient-centred design can support better health outcomes. By making it easier for individuals to access information about their screening options, connect with supportive healthcare providers, and navigate their care journey, we can help bridge the gap between innovative policies and real-world implementation.
For individuals eligible for cervical screening, the key message is clear: self-collection is a safe, accurate, and convenient option.The journey toward cervical cancer elimination requires innovative approaches that address the diverse needs and preferences of all individuals. Self-collection represents a powerful tool in this effort, but its success ultimately depends on the commitment of healthcare systems and practitioners to embrace change in service of better health outcomes for all—a mission that June Health is proud to support.
References
Arbyn, M., Smith, S. B., Temin, S., Sultana, F., Castle, P., & Collaboration Self-Sampling HPVT. (2018). Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: Updated meta-analyses. BMJ, 363, k4823. https://doi.org/10.1136/bmj.k4823
Camara, H., Zhang, Y., Lafferty, L., Vallely, A., Guy, R., & Kelly-Hanku, A. (2021). Self-collection for HPV-based cervical screening: A qualitative evidence meta-synthesis. BMC Public Health, 21(1), 1503. https://doi.org/10.1186/s12889-021-11554-6
Creagh, N. S., Saunders, T., Brotherton, J., Hocking, J., Karahalios, A., Saville, M., Smith, M., & Nightingale, C. (2024). Practitioners support and intention to adopt universal access to self-collection in Australia’s National Cervical Screening Program. Cancer Medicine, 13, e7254. https://doi.org/10.1002/cam4.7254
Qaseem, A., Humphrey, L. L., Harris, R., Starkey, M., & Denberg, T. D. (2014). Screening pelvic examination in adult women: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 161(1), 67-72. https://doi.org/10.7326/M14-0701
Serrano, B., Ibáñez, R., Robles, C., Peremiquel-Trillas, P., de Sanjosé, S., & Bruni, L. (2022). Worldwide use of HPV self-sampling for cervical cancer screening. Preventive Medicine, 154, 106900. https://doi.org/10.1016/j.ypmed.2021.106900
Smith, M. A., Sherrah, M., Sultana, F., Creagh, N., Wrede, C. D., Canfell, K., & Saville, M. (2022). National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: Observational study. BMJ, 376, e068582. https://doi.org/10.1136/bmj-2021-068582
